Skip to main content

The efficacy of concentrated growth factor and platelet-rich fibrin as scaffolds in regenerative endodontic treatment applied to immature permanent teeth: a retrospective study

Abstract

Background

The aim of this retrospective study was to compare the efficacy of concentrated growth factor (CGF) and platelet-rich fibrin (PRF) as scaffolds in regenerative endodontic therapy (RET).

Methods

Necrotic immature permanent teeth treated with regenerative endodontic therapy during January 2018 to August 2022 were divided into the CGF and PRF groups according to the scaffold. The CGF and PRF groups included 7 and 6 teeth, respectively. The efficacy of regenerative endodontic therapy was analyzed based on the clinical and radiological outcomes at three different follow up periods: T1 (3–6 months), T2 (6–12 months) and T3 (12–24 months). Statistical analysis was performed using the independent T test, Mann-Whitney test and Fisher’s exact test at a significance level of 0.05.

Results

The success rate of each stage in both groups was 100%. Through quantitative comparison of radiographic outcomes, there was no statistically significant difference between the two groups in terms of root development and periapical lesion healing at each stage, except that the increase rate of radiographic root area in PRF group in the T3 stage was above one in CGF group with statistically significance.

Conclusions

Both CGF and PRF had a similar clinical performance regarding resolution of clinical signs and symptoms, periapical lesion healing, and continued root development as scaffolds in RET. Further prospective studies with large samples for longer follow-up periods are needed.

Peer Review reports

Background

Regenerative endodontic therapy (RET) is a treatment method based on the concept of tissue engineering, which aim to promote root development of necrotic immature permanent teeth and the regeneration of the pulp-dentin complex [1]. Such three elements of tissue engineering as seed cells, scaffold materials and growth factors have an essential impact on the efficacy of RET [2, 3]. A suitable scaffold can provide a suitable location for seed cells and biological conditions conducive to cell metabolism, and regulate their differentiation and proliferation.

The main scaffolds for regenerative endodontic therapy are autologous blood clot, autologous platelet concentrate, biomaterial scaffold, and so on [4]. At present, blood clots and autologous platelet concentrate are commonly used in clinic [5]. The traditional method in RET is to stimulate apical bleeding, fill the root canal with blood, and use blood clots (BC) as scaffolds for pulp revascularization. Blood clot as a scaffold in RET had a good practicability and success rate [6]. However, it was found that clinically there were quite a few cases with no or insufficient blood clots which were disable to fill the root canal or support the pressure from the crown sealing material, leading to treatment failure [7]. At the same time, for necrotic mandibular premolars caused by developmental dental anomalies, there was a risk of nerve injury by using files to stimulate bleeding outside the apical foramen because of the physiological and anatomical position of mental foramina and root apices [8]. Therefore, it is necessary to find scaffolds to replace blood clots. Endogenous materials replacing blood clots as scaffolds include platelet‑rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF). The phenomenon of root development was observed by applying PRF to the RET of necrotic immature permanent teeth, which proved the feasibility of using PRF instead of traditional blood clot [9].

Saccol et al. obtained the third generation of platelet concentrate, concentrated growth factor, by precise variable speed centrifugation with a specific centrifuge [10]. It is a fibrin matrix with high concentration of growth factors and 3D network structure, which promote soft and hard tissue repair and regeneration, by improvement of cell migration and facilitation of neovascularization [11]. CGF may play an role in vascular maintenance and angiogenesis due to its inclusion of CD34-positive cells [12]. Besides CGF with a stronger regeneration ability contains more growth factors and fibrin matrix than PRF on account of the preparation of CGF adopts differential centrifugation with higher separation efficiency [13,14,15].

Platelet concentrate products have good biological characteristics and are easy to produce. In recent years, they have been widely used in regenerative treatment of oral medicine, such as periodontal tissue regeneration and orthodontic tooth movement [16, 17]. CGF has shown superior potential for tissue regeneration in clinical and biotechnology applications. However, there are still relatively few reports on the application of CGF in RET. The objective of this study was to evaluate and compare the efficacy of CGF and PRF for RET in necrotic immature permanent teeth, and to select an ideal scaffold.

Methods

Inclusion and exclusion criteria

The study design and clinical procedures were conducted in accordance with the Helsinki Declaration and were approved by the ethical committee of the Stomatological Hospital of Chongqing Medical University (ID: CQHS-REC-2022(LSNO.106)). Informed consent to participate in the study was obtained from participant’s legal guardian. Through the inquiry of the CGF/PRF centrifuge operating records during January 2018 to August 2022, the cases of patients treated with RET were preliminarily identified.

Clinical records of potential cases were reviewed to determine eligibility for the study with pre-determined inclusion and exclusion criteria. Inclusion criteria: (1) patients had already been treated must be at least 6–16 years old at the time of treatment and the necrotic immature permanent teeth development should be at Nolla 7–9 stages [18]. The Nolla stage was determined by two authors based on Fig. 1 and periapical radiographs. Any disagreement was resolved by discussion with a third author; (2) use CGF or PRF as scaffolds; (3) have complete regenerative endodontic procedures including the final restoration; (4) recall was recorded in clinical records for at least 3 months. Exclusion criteria: (1) serious loss of case data; (2) X-ray image distortion cannot be corrected; (3) According the periapical index (PAI) scoring system [19], teeth with periapical lesion whose PAI scores were not 3–4.

Fig. 1
figure 1

Nolla stage diagram

Data extraction

The included cases were divided into CGF group and PRF group according to the different scaffolds used. Data were extracted from the clinical records of these included cases such as demographic factors, tooth position, etiology, preoperative signs and symptoms, intraoperative treatment details, and follow-up time. Data were recorded and organized using Microsoft Excel (Microsoft Corp., Redmond, W A, USA). The preoperative and follow-up radiographs were taken with the dental X-ray machine (65 kV, 7 mA, and 0.1–0.2 s scan time) using the standardized paralleling technique. All radiographs were saved in jpg format (Figs. 2a–d and 3a–d).

Fig. 2
figure 2

#21 in a 11-year-old boy of CGF group (a) The pre-operative periapical radiograph. (b) The immediate post-operative periapical radiograph. (c) The post-operative periapical radiograph at the 4-month follow-up. (c) The post-operative periapical radiograph at the 16-month follow-up

Fig. 3
figure 3

#11 in a 7-year-old girl of PRF group (a) The pre-operative periapical radiograph. (b) The post-operative periapical radiograph at the 3-month follow-up. (c) The post-operative periapical radiograph at the 6-month follow-up. (c) The post-operative periapical radiograph at the 15-month follow-up

Preparation of CGF/PRF

Intravenous blood sample (10ml) from the patient was obtained and drawn into a disposable 10 ml nonanticoagulant tube. The tube was placed in a matching centrifuge device (DT-F4, Chengdu Dengtuo Medical Instrument Co., LTD). Depending on the scaffold to be prepared, different centrifugation programs on panel were selected. The PRF was centrifuged at 3000 rpm for 10 min at room temperature. CGF was centrifuged at variable rpm for 15 min, which mainly consist of 2600 rpm for 2 min, 2300 rpm for 4 min, 2600 rpm for 4 min, and 2850 rpm for 3 min. After centrifugation, three distinct layers occurred in the tube: serum layer at the uppermost, CGF/PRF layer at the middle, and red blood cell layer at the bottom. The fibrin gel from the middle layer was separated and put into a specially-made and box-shaped separator to make into a membrane (Fig. 4). The CGF/PRF membrane was then trimmed to a suitable size to match the volume of root canal.

Fig. 4
figure 4

Box-shaped separator, sterile scissor, and CGF clot

Treatment procedure

Although this was a retrospective study spanning several years and no specific clinical protocol was implemented before the implementation of treatment, the general processes referred to the recommendations of the American Association of Endodontists for RET [20]. All cases were completed by endodontists experienced in RET.

At the first visit, round burs or fissure burs were used to prepare the access chamber under the isolation of the rubber dam. The pulp chamber and root canal were disinfected by 10-20mL of 1–3% NaOCl with minimal or no mechanical instrumentation. The pulp chamber and root canal were dried with sterile cotton pellet and sterile paper points. Then calcium hydroxide was placed in the root canal. Glass ionomer cement or temporary sealing materials were used to temporarily restore the access cavity.

RET was usually performed 2 weeks later. If the tooth still appeared obvious clinical symptoms, the steps at the first visit were repeated. After removal of temporary restoration, the saline combined with P5 Ultrasound (Satelec, France) was used to rinse the calcium hydroxide by means of the newtron bidirectional oscillation (vibration frequency: 28-36KHZ; intervals of 10 min /5 minutes). The irrigation was finalized with 10–15 mL of 17% EDTA solution, and the tooth was dried with sterile cotton pellet and sterile paper points. The CGF/PRF layer was carefully detached and fragmented. The CGF/PRF fragments were placed in the root canal to the level of cemento-enamel junction (CEJ). The iRoot BP (Innovative Bioceramix, Vancouver, BC, Canada) was placed on the CGF/PRF fragments to form a plug. The access cavity was filled with flowable composite (Beautifil Flow Plus, SHOFO, Japan) and then with packable composite (3M, USA) when the iRoot BP material stiffened after one week.

Assessment of outcome

The absence of any clinical symptoms with complete resolution of periapical lesion were considered as indicators of healing or success [21]. Given the extended duration required for complete resolution of periapical lesions, clinical success in the study is defined as the absence of any clinical symptoms with the reduction or elimination in the size of the periapical lesion and no need for endodontic retreatment during the recall period.

The root was retrospectively evaluated by pre-operative and follow-up periapical radiographs. Independent analysis was performed in T1 (3–6 months), T2 (7–12 months), and T3 (12–24 months) follow-up [22]. The pre-operative and follow-up periapical radiographs saved in JPG format were opened in the Image J software program (National Institutes of Health, USA) and digitally measured after standardization provided by TurboReg plugin (Swiss Federal Institute of Technology, Switzerland).

The apical foramen diameter, root length, radiographic root area (RRA) and periapical lesion (PAL) were measured referred to the study of Jun et al. [22]. The straight-line tool was used to measure the apical foramen diameter and root length. Apical foramen diameter was measured as the straight line crossing the apex of the root from the mesial to distal. Root length was obtained as the average of 2 straight lines from the mesial and distal cemento-enamel junction to the root apex at the mesial and distal sides. The polygon tool was used to measure RRA and PAL. RRA = root outline under CEJ- root canal space. PAL = the area of periapical area with significantly reduced bone density. The measurement was shown schematically in Fig. 5.

Fig. 5
figure 5

 A schematic of digital measurements: (a) apical width. (b) root length. (c) RRA. (d) periapical lesion size

All measurements were performed by two observers using software at a one-week interval and the average of two measurements in each group was recorded. The results of quantitative analysis in periapical area were described in change ratio (%) which was calculated as follows: (preoperative measured value − postoperative measured value) / preoperative measured value × 100%.

Statistical analysis

SPSS 22.0 software was used to analyze the data. The intraclass correlation (ICC) test was performed to evaluate the reliability of the examiner. When the data coincided with normal distribution, the measured value was expressed as mean ± standard deviation. When the data didn’t coincide with normal distribution, the measured value was expressed as median, first quartile and third quartile. T test and Mann-Whitney test were applied to difference comparison among continuous variables, while dichotomous variables were evaluated by Fisher’s exact test. The significance level was set at P < 0.05.

Results

The study included 13 teeth from 13 patients (9 Females and 4 males), in which 7 and 6 teeth were treated with CGF and PRF, respectively. The average age of patients in CGF group and PRF group was 11.43 years (10–15 years) and 10.67 years (7–14 years), respectively. The demographic characteristics of the study population were shown in Table 1. There was no significant difference in gender, age, etiology, tooth type, and Nolla stage between the two groups (P > 0.05). The ICCs were over 0.8, which indicated that the measurement made by the observer was reliable over time.

Table 1 Demographics and baseline characteristics of the patients

In order to determine whether there were differences between CGF group and PRF group in terms of apical closure, root length, root canal thickness, and periapical lesion, we quantified the changes of preoperative and postoperative periapical radiographs according to follow-up periods. The specific results were shown in Table 2.

Table 2 Quantitative radiographic outcomes of the patients [Mean ± standard deviation/median (25-75%)]

In the T1 (3–6 months), all the clinical symptoms of the teeth were eliminated, and for both groups, the success rate of RET were 100%. There was no significant difference between CGF group and PRF group in the reduction rate of apical foramen width, the increase rate of root length, the increase rate of RRA, and the reduction rate of periapical lesions (P > 0.05).

In the T2 (6–12 months), the clinical symptoms of all teeth were eliminated, and for both groups, the success rate of RET were 100%. There was one calcification case in each group, respectively. There was no significant difference between CGF group and PRF group in the reduction rate of apical foramen width, the increase rate of root length, the increase rate of RRA and the reduction rate of periapical lesions (P > 0.05).

In the T3 (12–24 months), the clinical symptoms of all teeth were eliminated, and for both groups, the success rate of RET were 100%. There was no significant difference between CGF group and PRF group in the reduction rate of apical foramen width, the increase rate of root length, and the reduction rate of periapical lesions (P > 0.05). Conversely, the increase rate of RRA of the PRF group was statistically significantly higher than the CGF group (P < 0.05).

Discussion

In this study, in order to compare the curative effect of each stage objectively, the follow-up time was divided into T1, T2 and T3 stages because of the lack of standardization of case follow-up. The primary goal of RET was to eliminate clinical symptoms and manifestations of periapical lesion healing, which we defined as success. The present study indicated that the success rate of PRF and CGF in each stage of RET was 100%, and there was obvious periapical lesion reduction in the T1 stage. It was consistent with the previous study whose result was that compared with BC, PRF had similar effects on apical closure, dentin wall thickening, apical healing and root lengthening [23, 24]. However, another study revealed that the long-term effect of BC group was stable and the success rate was high, while the long-term success rate of CGF group decreased gradually [25].

Apical closure and root lengthening are important indicators of root development and the thickness of root canal represents the fracture resistance of tooth root. CGF was placed in the root canal of the immature single-rooted teeth in the beagle dogs after pulpectomy and then after 8 weeks the results showed that there was a continuing root development in immature teeth and regenerated pulp-like tissues in root canal [26]. PRF composite dental pulp stem cells (DPSCs) were placed into the root canal and subcutaneously in nude mice. The results showed that the transplantation of DPSC/PRF structure not only promoted the regeneration of pulp-like tissues and the rich distribution of capillaries, but also promoted the deposition of regenerated dentin along the intracanal walls [27]. These in vitro studies showed that both CGF and PRF can promote pulp and dentin regeneration. In this study, the apical foramen closure and the root lengthening of the two groups were facilitated in different degrees, which aligns with findings from certain case reports [28, 29]. There was no significant difference between the two groups, which is consistent with an in vitro study suggesting that the impact on apical papilla stem cells did not show significant differences between CGF and PRF [30].

The results of quantitative measurement of RRA showed that the root canal wall of both CGF group and PRF group had hard tissue growth. Except that the increase rate of RRA in PRF group in the T3 stage was above one in CGF group with statistically significance, there was no significant difference in the increase rate of RRA between the two groups in T1 and T2 stage. This was consistent with the previous finding that PRF more effectively promoted in expression levels of osteogenic/odontoblast-related genes than CGF [30]. Also, the non-standardization of measurements cannot be ruled out as the cause of the discrepancy of RRA in T3 stage. In contrast to this study, Mahendran et al. [31] reported that CGF could significantly promoted root development compared with PRF in early stage, but the benefit diminished at the 18-month follow-up. This difference was attributed to CGF having a denser fibrin matrix and a higher concentration of growth factors than PRF. Additionally, the study by Mahendran et al. utilized cone-beam computed tomography for radiographic assessment, which is more accurate than periapical radiographs. Moreover, the age of the cases included in their study was significantly older than in our study, which could also contribute to the observed differences.

It’s worth noting that the 20% cutoff point of the radiographic increment was usually used as threshold of clinical significance in quantitative analysis of root changes, which was regarded as avoiding overestimation of the negligible root development evidence and the radiographic error. The 20% threshold was not introduced in this study because it was an arbitrary figure and was not based on scientifical testing. Nevertheless, based on this consideration, it was suggested that the present study results should be interpreted conservatively. It is acknowledged that emphasizing quantitative analysis instead of a threshold value may result in a higher standard deviation (Fig. 6), which is consistent with previous studies [29], that also reported a relatively high standard deviation.

Fig. 6
figure 6

Comparison of apical width reduction ratio, root length increase ratio and RRA increase ratio with mean ± standard deviation in T1, T2 and T3 between two groups

Ulusoy et al. conducted a randomized controlled study on the clinical efficacy of PRP, PRF, and BC in dental pulp revascularization and found that the presence of scaffold could significantly reduce the incidence of root canal calcification [32]. In this study, in the T2 stage, there was one case of root canal calcification in CGF group and one case in PRF group. There was no significant difference in improving the complication of calcification between the two groups. Pulp vitality recovery is the third-level goal of RET. It has been observed that pulp vitality recovery is positively correlated with root development [33]. A preliminary study found that the incidence of positive sensitivity response for electric pulp testing in necrotic immature permanent teeth was 25% [34]. Due to the lack of records of sensibility test in medical records, this study lacks the comparison of pulp vitality responses.

In addition to the insufficient number of cases and the inherent bias of retrospective studies, this study also had methodological limitations. One of the limitations is that the process of obtaining platelet derivatives lacks standardization, which could result in errors [35]. And the standardization of measurement depended on ImageJ software and TurboReg plugin. In practice, different angulation of periapical X-ray may lead to vastly different measurement. While this study indicated no significant difference between CGF and PRF regarding the resolution of clinical signs and symptoms, periapical lesion healing, and continued root development as scaffolds in RET, the small sample size was insufficient to draw definitive conclusion. This provided useful information for the selection of scaffolds. Nevertheless, more randomized prospective controlled studies are needed to confirm the ideal scaffold.

Conclusions

Both CGF and PRF demonstrated similar clinical performance in terms of resolution of clinical signs and symptoms, periapical lesion healing, and continued root development as scaffolds in RET. Further prospective studies with large samples and longer follow-up periods are needed to support the conclusion.

Data Availability

All data generated or analyzed during this study are included in the article.

Abbreviations

RET:

Regenerative endodontic therapy

CGF:

Concentrated growth factor

PRF:

Platelet-rich fibrin

RRA:

Radiographic root area

PAL:

Periapical lesion

CEJ:

Cement-enamel junction

DPSCs:

Dental pulp stem cells

References

  1. Schmalz G, Widbiller M, Galler KM. Clinical perspectives of pulp regeneration. J Endod. 2020;46(9s):161–s174.

    Article  Google Scholar 

  2. Hargreaves K, Diogenes A, Teixeira F. Treatment options: biological basis of regenerative endodontic procedures. Pediatr Dent. 2013;35(2):129–40.

    PubMed  Google Scholar 

  3. Jung C, Kim S, Sun T, Cho YB, Song M. Pulp-dentin regeneration: current approaches and challenges. J tissue Eng. 2019;10:2041731418819263.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vatankhah M, Najary S, Dianat O. Clinical, Radiographic, and histologic outcomes of regenerative endodontic treatment in human immature teeth using different Biological Scaffolds: a systematic review and Meta-analysis. Current stem cell research & therapy; 2022.

  5. Zhou R, Wang Y, Chen Y, Chen S, Lyu H, Cai Z, Huang X. Radiographic, histologic, and Biomechanical evaluation of combined application of platelet-rich fibrin with blood clot in regenerative endodontics. J Endod. 2017;43(12):2034–40.

    Article  PubMed  Google Scholar 

  6. Dabbagh B, Alvaro E, Vu D, Rizkallah J, Schwartz S. Clinical complications in the revascularization of immature necrotic permanent teeth. Pediatr Dent. 2012;34(5):414–7.

    PubMed  Google Scholar 

  7. Bezgin T, Yilmaz A, Celik B, Kolsuz M, Sonmez H. Efficacy of platelet-rich plasma as a scaffold in regenerative endodontic treatment. J Endod. 2015;41(1):36–44.

    Article  PubMed  Google Scholar 

  8. Denio D, Torabinejad M, Bakland L. Anatomical relationship of the mandibular canal to its surrounding structures in mature mandibles. J Endod. 1992;18(4):161–5.

    Article  PubMed  Google Scholar 

  9. Lv H, Chen Y, Cai Z, Lei L, Zhang M, Zhou R, Huang X. The efficacy of platelet-rich fibrin as a scaffold in regenerative endodontic treatment: a retrospective controlled cohort study. BMC Oral Health. 2018;18(1):139.

    Article  PubMed  PubMed Central  Google Scholar 

  10. L S: International academy of implant prosthesis and osteoconnection. 2006.12.4.

  11. Hong S, Li L, Cai W, Jiang B. The potential application of concentrated growth factor in regenerative endodontics. Int Endod J. 2019;52(5):646–55.

    Article  PubMed  Google Scholar 

  12. Kikuchi-Taura A, Soma T, Matsuyama T, Stern DM, Taguchi A. A new protocol for quantifying CD34(+) cells in peripheral blood of patients with cardiovascular disease. Tex Heart Inst J. 2006;33(4):427–9.

    PubMed  PubMed Central  Google Scholar 

  13. Sohn DS, Heo JU, Kwak DH, Kim DE, Kim JM, Moon JW, Lee JH, Park IS. Bone regeneration in the maxillary sinus using an autologous fibrin-rich block with concentrated growth factors alone. Implant Dent. 2011;20(5):389–95.

    Article  PubMed  Google Scholar 

  14. Li Z, Liu L, Wang L, Song D. The effects and potential applications of concentrated growth factor in dentin-pulp complex regeneration. Stem Cell Res Ther. 2021;12(1):357.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kim TH, Kim SH, Sándor GK, Kim YD. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol. 2014;59(5):550–8.

    Article  PubMed  Google Scholar 

  16. Mheissen S, Daraqel B, Alzoubi E, Khan H. Effectiveness of platelet-rich concentrates on the rate of orthodontic tooth movement: a systematic review and meta-analysis. Eur J Orthod. 2023;45(2):196–207.

  17. Mijiritsky E, Assaf HD, Peleg O, Shacham M, Cerroni L, Mangani L. Use of PRP, PRF and CGF in Periodontal Regeneration and Facial Rejuvenation-A Narrative Review. Biology 2021, 10(4).

  18. Nolla CM. The development of permanent teeth. J Dent Child. 1960;27:254–66.

    Google Scholar 

  19. Orstavik D, Kerekes K, Eriksen HM. The periapical index: a scoring system for radiographic assessment of apical periodontitis. Endod Dent Traumatol. 1986;2(1):20–34.

    Article  PubMed  Google Scholar 

  20. American Association of Endodontists. Clinical Considerations for Regenerative Procedures. Available at: http://www.aae.org/regeneration/. 2018.

  21. Friedman S, Mor C. The success of endodontic therapy–healing and functionality. J Calif Dent Assoc. 2004;32(6):493–503.

    Article  PubMed  Google Scholar 

  22. Jun JH, Chun KA, Kum KY, Lee W, Shon WJ, Yoo YJ, Baek SH. Effect of mineral trioxide aggregate plug location on root development in regenerative endodontic procedure. Odontology. 2021;109(2):411–21.

    Article  PubMed  Google Scholar 

  23. Kritika S, Sujatha V, Srinivasan N, Renganathan SK, Mahalaxmi S. Prospective cohort study of regenerative potential of non vital immature permanent maxillary central incisors using platelet rich fibrin scaffold. Sci Rep. 2021;11(1):13679.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Panda S, Mishra L, Arbildo-Vega HI, Lapinska B, Lukomska-Szymanska M, Khijmatgar S, Parolia A, Bucchi C, Fabbro MD. Effectiveness of autologous platelet concentrates in management of young immature necrotic permanent Teeth-A systematic review and Meta-analysis. Cells 2020, 9(10).

  25. Yang F, Yu L, Li J, Cheng J, Zhang Y, Zhao X, Song G. Evaluation of concentrated growth factor and blood clot as scaffolds in regenerative endodontic procedures: a retrospective study. Australian endodontic journal: the journal of the Australian Society of Endodontology Inc 2022.

  26. Xu F, Qiao L, Zhao Y, Chen W, Hong S, Pan J, Jiang B. The potential application of concentrated growth factor in pulp regeneration: an in vitro and in vivo study. Stem Cell Res Ther. 2019;10(1):134.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chen YJ, Zhao YH, Zhao YJ, Liu NX, Lv X, Li Q, Chen FM, Zhang M. Potential dental pulp revascularization and odonto-/osteogenic capacity of a novel transplant combined with dental pulp stem cells and platelet-rich fibrin. Cell Tissue Res. 2015;361(2):439–55.

    Article  PubMed  Google Scholar 

  28. Nivedhitha M, Jacob B, Ranganath A. Concentrated growth factor: a novel platelet concentrate for revascularization of Immature Permanent Teeth-A Report of two cases. Case Rep dentistry. 2020;2020:1329145.

    Google Scholar 

  29. Nawal R, Utneja S, Sharma V, Yadav S, Talwar S. Long-term follow-up of traumatized immature necrotic permanent teeth treated with regenerative endodontic protocol using platelet-rich fibrin: a prospective case series. J conservative dentistry: JCD. 2020;23(4):417–21.

    Article  PubMed  Google Scholar 

  30. Hong S, Chen W, Jiang B. A comparative evaluation of concentrated growth factor and platelet-rich fibrin on the Proliferation, Migration, and differentiation of human stem cells of the apical papilla. J Endod. 2018;44(6):977–83.

    Article  PubMed  Google Scholar 

  31. Kavitha M, Shakthipriya S, Arunaraj D, Hemamalini R, Velayudham S, Bakthavatchalam B. Comparative evaluation of platelet-rich fibrin and concentrated growth factor as Scaffolds in Regenerative Endodontic Procedure: a Randomized Controlled Clinical Trial. J Contemp Dent Pract. 2022;23(12):1211–7.

    Article  PubMed  Google Scholar 

  32. Ulusoy AT, Turedi I, Cimen M, Cehreli ZC. Evaluation of blood clot, platelet-rich plasma, platelet-rich fibrin, and platelet pellet as Scaffolds in Regenerative Endodontic treatment: a prospective Randomized Trial. J Endod. 2019;45(5):560–6.

    Article  PubMed  Google Scholar 

  33. Chrepa V, Joon R, Austah O, Diogenes A, Hargreaves K, Ezeldeen M, Ruparel N. Clinical outcomes of immature teeth treated with regenerative endodontic Procedures-A San Antonio Study. J Endod. 2020;46(8):1074–84.

    Article  PubMed  Google Scholar 

  34. Li J, Zheng L, Daraqel B, Liu J, Hu Y. Treatment outcome of regenerative endodontic procedures for necrotic immature and mature permanent teeth: a systematic review and Meta-analysis based on randomised controlled trials. Oral Health Prev Dent. 2023;21(1):141–52.

    PubMed  Google Scholar 

  35. Tabatabaei F, Aghamohammadi Z, Tayebi L. In vitro and in vivo effects of concentrated growth factor on cells and tissues. J biomedical Mater Res Part A. 2020;108(6):1338–50.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by Chongqing Talent Program: Innovative leading talents (Medical field, CQYC20210303384); Chongqing Medical Scientific Research Project (2018ZDXM020).

Author information

Authors and Affiliations

Authors

Contributions

Jiahua Li is the first author. Leilei Zheng obtained funding. Jiahua Li and Yun Hu designed the study. Leilei Zheng, and Jing Liu collected the data. Jiahua Li and Baraa Daraqel were involved in data cleaning, and analysis of data. Jiahua Li drafted the manuscript. Jiahua Li and Baraa Daraqel contributed to the interpretation of the results and critical revision of the manuscript for important intellectual content and approved the final version of the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Yun Hu.

Ethics declarations

Ethics approval and consent to participate

The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the ethical committee of the Stomatological Hospital of Chongqing Medical University. The informed consent was obtained from the Legally authorized Representatives of Participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Zheng, L., Daraqel, B. et al. The efficacy of concentrated growth factor and platelet-rich fibrin as scaffolds in regenerative endodontic treatment applied to immature permanent teeth: a retrospective study. BMC Oral Health 23, 482 (2023). https://doi.org/10.1186/s12903-023-03164-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-023-03164-y

Keywords